ProKidney Corp. (PROK)
USD 0.7
(14.57%)
USD 0.7
(14.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 3.16 Million | 3.03 Million | 1.98 Million | - | - |
| Gross Profit | -3.16 Million | -3.03 Million | -1.98 Million | - | - |
| Operating Expenses | 151.52 Million | 153 Million | 55.11 Million | 27.02 Million | 79.38 Million |
| Selling, General and Administrative Expenses | 44.81 Million | 70.93 Million | 8.85 Million | 5.98 Million | 4.15 Million |
| Research and Development Expenses | 106.7 Million | 82.07 Million | 46.25 Million | 21.04 Million | 75.22 Million |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 151.52 Million | 153 Million | 55.11 Million | 27.02 Million | 79.38 Million |
| Operating Income | -151.52 Million | -153 Million | -55.11 Million | -27.02 Million | -19.15 Million |
| Interest Expense | 12 Thousand | 215 Thousand | - | - | - |
| Income Tax Expense | 5.99 Million | 896 Thousand | 38 Thousand | -232 Thousand | 361 Thousand |
| Earnings before Tax | -129.45 Million | -147.23 Million | -55.1 Million | -26.98 Million | -79.25 Million |
| Net Income | -35.46 Million | -148.13 Million | -55.14 Million | -26.74 Million | -79.61 Million |
| Earnings Per Share Basic | -0.57 | -2.41 | -0.30 | -0.14 | -1.01 |
| Earnings Per Share Diluted | -0.57 | -2.41 | -0.30 | -0.14 | -1.01 |
| Weighted Average Shares Outstanding | 61.71 Million | 61.54 Million | 186.5 Million | 186.5 Million | 78.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.71 Million | 61.54 Million | 186.5 Million | 186.5 Million | 78.52 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -147.66 Million | -143.98 Million | -53.12 Million | -26.01 Million | -18.29 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 4.49 Million | - | - | - |
| Cost of Revenue | 964 Thousand | 832 Thousand | 1.03 Million | 3.16 Million | 861 Thousand | 706 Thousand |
| Gross Profit | -964 Thousand | -832 Thousand | 3.46 Million | -3.16 Million | -861 Thousand | -706 Thousand |
| Operating Expenses | 42.09 Million | 39.24 Million | 23.17 Million | 148.35 Million | 46.61 Million | 39.81 Million |
| Selling, General and Administrative Expenses | 12.68 Million | 12.01 Million | 651 Thousand | - | 14.41 Million | 13.45 Million |
| Research and Development Expenses | 29.4 Million | 27.23 Million | 22.52 Million | - | 32.19 Million | 26.36 Million |
| Other Expenses | -12.68 Million | - | - | - | - | - |
| Cost and Expenses | 43.05 Million | 40.07 Million | 24.21 Million | 151.52 Million | 46.61 Million | 39.81 Million |
| Operating Income | -43.05 Million | -40.07 Million | -24.21 Million | -151.52 Million | -30.09 Million | -39.81 Million |
| Interest Expense | 3000.00 | 2000.00 | 3000.00 | 12 Thousand | -2000.00 | 4000.00 |
| Income Tax Expense | -56 Thousand | 98 Thousand | 2.79 Million | 5.99 Million | 913 Thousand | 965 Thousand |
| Earnings before Tax | -38.52 Million | -35.23 Million | -18.93 Million | -129.45 Million | -41.07 Million | -33.85 Million |
| Net Income | -12.5 Million | -9.49 Million | -5.7 Million | -35.46 Million | -31 Million | -9.11 Million |
| Earnings Per Share Basic | -0.16 | -0.16 | -0.10 | - | -0.50 | -0.14 |
| Earnings Per Share Diluted | -0.16 | -0.16 | -0.10 | - | -0.50 | -0.14 |
| Weighted Average Shares Outstanding | 75.9 Million | 60.95 Million | 59.88 Million | 61.71 Million | 61.59 Million | 64.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.9 Million | 60.95 Million | 59.88 Million | 61.71 Million | 61.59 Million | 64.56 Million |
| Gross Margin | - | - | 0.77 | - | - | - |
| EBIT Margin | - | - | -5.16 | - | - | - |
| Profit Margin | - | - | -1.27 | - | - | - |
| EBITDA | -42.09 Million | -39.24 Million | -23.17 Million | - | -30.09 Million | -32.98 Million |
| Earnings Before Tax Margin | - | - | -5.39 | - | - | - |
KCPSUGIND
SRXXF
APLT
FBSE
300645
TMASF